Cargando…

CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study

BACKGROUND: Reports on the expression of CD38 in Sézary syndrome (SS), erythrodermic primary cutaneous T cell lymphoma with leukemic involvement, are limited. The aim of the present study is the analysis of the expression of CD38 by skin-infiltrating mononuclear cells and circulating T lymphocytes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quaglino, Pietro, Novelli, Mauro, Fava, Paolo, Ortolan, Erika, Astrua, Chiara, Tonella, Luca, Tomasini, Carlo Francesco, Senetta, Rebecca, Ribero, Simone, Ponti, Renata, Fierro, Maria Teresa, Funaro, Ada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896155/ https://www.ncbi.nlm.nih.gov/pubmed/35251370 http://dx.doi.org/10.1155/2022/3424413

Ejemplares similares

Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System
por: Roccuzzo, Gabriele, et al.
Publicado: (2022)

Treatment of Advanced Metastatic Melanoma
por: Quaglino, Pietro, et al.
Publicado: (2021)

Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications
por: Tonella, Luca, et al.
Publicado: (2021)

Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit
por: Quaglino, Pietro, et al.
Publicado: (2021)

Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
por: Roccuzzo, Gabriele, et al.
Publicado: (2021)

Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient
por: Quaglino, Pietro, et al.
Publicado: (2021)

Clinical Significance of Distant Metastasis-Free Survival (DMFS) in Melanoma: A Narrative Review from Adjuvant Clinical Trials
por: Amabile, Simone, et al.
Publicado: (2021)

The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
por: Pileri, Alessandro, et al.
Publicado: (2021)

Alopecia areata after COVID-19 vaccination
por: Gallo, Giuseppe, et al.
Publicado: (2022)

Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
por: Gullo, Giulia, et al.
Publicado: (2022)

Identification of p38 beta as a therapeutic target for the treatment of Sézary Syndrome
por: Bliss-Moreau, Meghan, et al.
Publicado: (2014)

Non-Sentinel Lymph Node Detection during Sentinel Lymph Node Biopsy in Not-Complete-Lymph-Node-Dissection Era: A New Technique for Better Staging and Treating Melanoma Patients
por: Picciotto, Franco, et al.
Publicado: (2021)

Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients
por: Zocco, Davide, et al.
Publicado: (2020)

Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
por: Rubatto, Marco, et al.
Publicado: (2023)

Hepatic Infiltration with Malignant T-cells Manifesting as Impending Acute Liver Failure in Sezary Syndrome
por: Zhang, Yumeng, et al.
Publicado: (2020)

Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients
por: Zugna, D, et al.
Publicado: (2018)

Alemtuzumab in refractory Sézary syndrome
por: Reifs, Carmen María Alcántara, et al.
Publicado: (2016)

Plantar keratoderma of Sézary syndrome
por: Fragkos, Konstantinos C.
Publicado: (2017)

Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023)

Dupilumab-Associated Sezary Syndrome
por: Hamp, Austin, et al.
Publicado: (2023)

Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
por: Liberini, Virginia, et al.
Publicado: (2021)

Better method for detection of CD30: Immunohistochemistry or flow cytometry?
por: Higashi, Morihiro, et al.
Publicado: (2021)

Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience
por: Rubatto, Marco, et al.
Publicado: (2023)

Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment
por: Borcherding, Nicholas, et al.
Publicado: (2022)

Integrated Genomic Analysis of Sézary Syndrome
por: Mao, Xin, et al.
Publicado: (2011)

A mouse model for the Sézary syndrome
por: Doebbeling, Udo
Publicado: (2010)

Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies
por: Ricci, Alessia Andrea, et al.
Publicado: (2023)

Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry
por: Abdel-Ghafar, Afaf Abdel-Aziz, et al.
Publicado: (2012)

Flow cytometry and immunohistochemistry of the mouse dural meninges for immunological and virological assessments
por: Roussel-Queval, Annie, et al.
Publicado: (2023)

Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome
por: Moerman-Herzog, Andrea, et al.
Publicado: (2020)

Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice
por: Roccuzzo, Gabriele, et al.
Publicado: (2022)

Ki‐67 assessment—agreeability between immunohistochemistry and flow cytometry in canine lymphoma
por: Rigillo, Antonella, et al.
Publicado: (2021)

Immunotherapy in transplanted patients: A special population that can no longer be ignored
por: Rubatto, Marco, et al.
Publicado: (2021)

Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
por: RAMONDETTA, Alice, et al.
Publicado: (2020)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018)

The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
por: Miyashiro, Denis, et al.
Publicado: (2022)

TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)

Nutritional Interventions for Patients with Melanoma: From Prevention to Therapy—An Update
por: Pellegrini, Marianna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_43mg0safhng5shcb8gimqol005